Table 2 Characteristics of the clinical index independent validation cohort in CAL- & IVIG-responsive KD, CAL and IVIG-resistant KD.
Group | CAL- & IVIG-responsive (n = 42) | CAL+ (n = 7) | IVIG-resistant (n = 11) |
|---|---|---|---|
Male, N | 23 | 5 | 6 |
Age at onset (years) | 2.3(0.8–3.7) | 2.3(1.7–2.8) | 2.3(1.3–3.3) |
Body weight (kg) | 13.4(9.6–14.9) | 12.6(11.3–14) | 12.6(9.5–15.0) |
Illness days | 5.5(4.0–6.0) | 12.9(6.5–16.5) | 5.1(4.0–6.0) |
WBC (*109/L) | 12.7(10.6–15.1) | 11.2(8.1–12.1) | 12.5(7.9–15.3) |
#N (*109/L) | 7.7(4.9–9.4) | 5.4(3.0–6.3) | 8.7(3.6–11.9) |
Plt (*109/L) | 335.0(268.0–379.0) | 574.5(462.0–620.0) | 359.3(330.5–385.5) |
ESR (mm/h) | 56.1(34.3–77.3) | 52.3(36–62.3) | 54.2(40.5–68.0) |
CRP (mg/L) | 69.9(35.0–89.0) | 52.0(54.3–60.0) | 69.3(54.8–94.6) |
Z-worst | 0.87(0.55–1.55) | 6.22(2.77–6.41) | 1.17(0.65–1.60) |
